To this end, we screened a total of 1735 females for WBC BRCA1 promoter methylation, 908 of whom had been diagnosed with breast cancer, and whose median age was 49 years, and 827 healthy female controls ranging in age from 15 to 50 years. This evidence concerns the gene BRCA1 and breast carcinoma.